Human T-cell leukemia virus type 2 Rex carboxy terminus is an inhibitory/stability domain that regulates rex functional activity and viral replication

Journal of Virology

Volumn 83, Issue 10, 2009, Pages 5232-5243

  Xie, Li ^a   Kesic, Matthew ^a   Yamamoto, Brenda ^a   Li, Min ^a   Younis, Ihab ^a   Lairmore, Michael D ^a,b   Green, Patrick L ^a,b  

^a OHIO STATE UNIVERSITY   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; ASPARTIC ACID; MUTANT PROTEIN; PHOSPHOPROTEIN; PROLINE; REX PROTEIN; SERINE; THREONINE; VIRUS PROTEIN; REX PROTEIN, HUMAN T LYMPHOTROPIC VIRUS 2; REX PROTEIN, HUMAN T-LYMPHOTROPIC VIRUS 2; TAX PROTEIN;

AMINO ACID SUBSTITUTION; ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL NUCLEUS; CELL PROLIFERATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 2; NONHUMAN; NUCLEOLUS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN STABILITY; PROTEIN STRUCTURE; PROVIRUS; RABBIT; STOP CODON; TRANSACTIVATION; VIRUS REPLICATION; WILD TYPE; ANIMAL; GENE DELETION; GENE EXPRESSION REGULATION; GENETICS; HELA CELL; HUMAN T CELL LEUKEMIA VIRUS INFECTION; LEUKEMIA CELL LINE; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; T LYMPHOCYTE; VIROLOGY;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN T-LYMPHOTROPIC VIRUS 2; ORYCTOLAGUS CUNICULUS;

ANIMALS; GENE EXPRESSION REGULATION, VIRAL; GENE PRODUCTS, REX; GENE PRODUCTS, TAX; HELA CELLS; HTLV-II INFECTIONS; HUMAN T-LYMPHOTROPIC VIRUS 2; HUMANS; JURKAT CELLS; PHOSPHORYLATION; PROTEIN STABILITY; RABBITS; SEQUENCE DELETION; T-LYMPHOCYTES; VIRUS REPLICATION;

EID: 65349138855     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.02271-08     Document Type: Article

References (55)

1. Adachi, Y., T. D. Copeland, C. Takahashi, T. Nosaka, A. Ahmed, S. Oroszlan, and M. Hatanaka. 1992. Phosphorylation of the Rex protein of human T-cell leukemia virus type I. J. Biol. Chem. 267:21977-21981.
2. Adachi, Y., T. Nosaka, and M. Hatanaka. 1990. Protein kinase inhibitor H-7 blocks accumulation of unspliced mRNA of human T-cell leukemia virus type I (HTLV-II). Biochem. Biophys. Res. Commun. 169:469-475. (Pubitemid 20216132)
3. Arnold, J., B. Yamamoto, M. Li, A. J. Phipps, I. Younis, M. D. Lairmore, and P. L. Green. 2006. Enhancement of infectivity and persistence in vivo by HBZ, a natural antisense coded protein of HTLV-1. Blood 107:3976-3982.
4. Bakker, A. L. X., C. T. Ruland, D. W. Stephens, A. C. Black, and J. D. Rosenblatt. 1996. Human T-cell leukemia virus type 2 Rex inhibits premRNA splicing in vitro at an early stage of spliceosome formation. J. Virol. 70:5511-5518. (Pubitemid 26240726)
5. Ballaun, C., G. R. Farrington, M. Dobrovnik, J. Rusche, J. Hauber, and E. Bohnlein. 1991. Functional analysis of human T-cell leukemia virus type I Rex-response element: direct RNA binding of Rex protein correlates with in vivo binding activity. J. Virol. 65:4408-4413.
6. Bangham, C. R., and M. Osame. 2005. Cellular immune response to HTLV-1. Oncogene 24:6035-6046.
7. Black, A. C., C. T. Ruland, M. T. Yip, J. Luo, B. Tran, A. Kalsi, E. Quan, I. S. Y. Chen, and J. D. Rosenblatt. 1991. Human T-cell leukemia virus type II Rex binding and activity requires an intact splice donor site and a specific RNA secondary structure. J. Virol. 65:6645-6653.
8. Bockus, B. J., and B. Schaffhausen. 1987. Phosphorylation of polyoma large T antigen: effects of viral mutations and cell growth state. J. Virol. 61:1147-1154.
9. Bogerd, H., and W. C. Greene. 1993. Dominant negative mutants of human T-cell leukemia virus type I Rex and human immunodeficiency virus type 1 Rev fail to multimerize in vivo. J. Virol. 67:2496-2502. (Pubitemid 23118843)
10. Bogerd, H. P., G. L. Huckaby, Y. F. Ahmed, S. M. Hanly, and W. C. Greene. 1991. The type 1 human T-cell leukemia virus (HTLV-I) Rex trans-activator binds directly to the HTLV-I Rex and the type 1 human immunodeficiency virus Rev RNA response elements. Proc. Natl. Acad. Sci. USA 88:5704-5708.
11. Boxus, M., J. C. Twizere, S. Legros, J. F. Dewulf, R. Kettmann, and L. Willems. 2008. The HTLV-1 Tax interactome. Retrovirology 5:76.
12. Cann, A. J., J. D. Rosenblatt, W. Wachsman, N. P. Shah, and I. S. Y. Chen. 1985. Identification of the gene responsible for human T-cell leukemia virus transcriptional regulation. Nature 318:571-574.
13. Chen, I. Y., J. McLaughlin, J. C. Gasson, S. C. Clark, and D. W. Golde. 1983. Molecular characterization of genome of a novel human T-cell leukaemia virus. Nature 305:502-505.
14. Ciminale, V., L. Zotti, D. M. D'Agostino, and L. Chieco-Bianchi. 1997. Inhibition of human T-cell leukemia virus type 2 Rex function by truncated forms of Rex encoded in alternately spliced mRNAs. J. Virol. 71:2810-2818. (Pubitemid 27119920)
15. Felber, B. K., H. Paskalis, C. Kleinman-Ewing, F. Wong-Staal, and G. N. Pavlakis. 1985. The pX protein of HTLV-I is a transcriptional activator of its long terminal repeats. Science 229:675-679.
16. Gatza, M. L., J. C. Watt, and S. Marriott. 2003. Cellular transformation by the HTLV-I Tax protein, a jack-of-all-trades. Oncogene 22:5141-5149.
17. Green, P. L., T. M. Ross, I. S. Y. Chen, and S. Pettiford. 1995. Human T-cell leukemia virus type II nucleotide sequences between env and the last exon of tax/rex are not required for viral replication or cellular transformation. J. Virol. 69:387-394.
18. Green, P. L., Y. Xie, and I. S. Y. Chen. 1991. The Rex proteins of human T-cell leukemia virus type II differ by serine phosphorylation. J. Virol. 65:546-550.
19. Green, P. L., M. T. Yip, Y. Xie, and I. S. Y. Chen. 1992. Phosphorylation regulates RNA binding by the human T-cell leukemia virus Rex protein. J. Virol. 66:4325-4330.
20. Hammes, S. R., and W. C. Green. 1993. Multiple arginine residues within the basic domain of HTLV-1 Rex are required for specific RNA binding and function. Virology 193:41-49.
21. Hidaka, M., J. Inoue, M. Yoshida, and M. Seiki. 1988. Post transcriptional regulator (rex) of HTLV-I initiates expression of viral structural proteins but suppresses expression of regulatory proteins. EMBO J. 7:519-523.
22. Hope, T. J., B. L. Bond, B. McDonald, N. P. Klein, and T. G. Parslow. 1991. Effector domains of human immunodeficiency virus type 1 Rev and human T-cell leukemia virus type I Rex are functionally interchangeable and share an essential peptide motif. J. Virol. 65:6001-6007.
23. xIII) regulators are required for the expression and replication of human T-cell leukemia virus type I genes. Proc. Natl. Acad. Sci. USA 84:3653-3657.
24. Jacobson, S., H. Shida, D. E. McFarlin, A. S. Fauci, and S. Koenig. 1990. Circulating CD8+ cytotoxic T lymphocytes specific for HTLV-I pX in patients with HTLV-I associated neurological disease. Nature 348:245-248.
25. Jeffery, K. J., K. Usuku, S. E. Hall, W. Matsumoto, G. P. Taylor, J. Procter, M. Bunce, G. S. Ogg, K. I. Welsh, J. N. Weber, A. L. Lloyd, M. A. Nowak, M. Nagai, D. Kodama, S. Izumo, M. Osame, and C. R. Bangham. 1999. HLA alleles determine human T-lymphotropic virus-I (HTLV-I) proviral load and the risk of HTLV-I-associated myelopathy. Proc. Natl. Acad. Sci. USA 96:3848-3853.
26. Kannagi, M., H. Shida, H. Igarashi, K. Kuruma, H. Murai, Y. Aono, I. Maruyama, M. Osame, T. Hattori, H. Inoko, et al. 1992. Target epitope in the Tax protein of human T-cell leukemia virus type I recognized by class I major histocompatibility complex-restricted cytotoxic T cells. J. Virol. 66:2928-2933.
27. Kim, J. H., P. A. Kaufman, S. M. Hanly, L. T. Rimsky, and W. C. Greene. 1991. Rex transregulation of human T-cell leukemia virus type II gene expression. J. Virol. 65:405-414.
28. Kusuhara, K., M. Anderson, S. M. Pettiford, and P. L. Green. 1999. Human T-cell leukemia virus type 2 Rex protein increases stability and promotes nuclear to cytoplasmic transport of gag/pol and env RNAs. J. Virol. 73:8112-8119. (Pubitemid 29441671)
29. Lairmore, M., and G. Franchini. 2007. Human T-cell leukemia virus types 1 and 2, p. 2071-2106. In B. Fields, D. Knipe, P. Howley, R. Chanock, T. Monath, J. Melnick, B. Roizman, and S. Straus (ed.), Fields virology, vol.5. Lippincott Williams and Wilkins, Philadelphia, PA.
30. Mulloy, J. C., T. Kislyakova, A. Cereseto, L. Casareto, A. LoMonico, J. Fullen, M. V. Lorenzi, A. Cara, C. Nicot, C. Giam, and G. Franchini. 1998. Human T-cell lymphotropic/leukemia virus type 1 Tax abrogates p53-induced cell cycle arrest and apoptosis through its CREB/ATF functional domain. J. Virol. 72:8852-8860. (Pubitemid 28471829)
31. Narayan, M., K. Kusuhara, and P. L. Green. 2001. Phosphorylation of two serine residues regulates human T-cell leukemia virus type 2 Rex function. J. Virol. 75:8440-8448. (Pubitemid 32768948)
32. Narayan, M., I. Younis, D. M. D'Agostino, and P. L. Green. 2003. Functional domain structure of human T-cell leukemia virus type 2 Rex. J. Virol. 77:12829-12840. (Pubitemid 37430677)
33. Nguyen, T., P. J. Sherratt, H. C. Huang, C. S. Yang, and C. B. Pickett. 2003. Increased protein stability as a mechanism that enhances Nrf2-mediated transcriptional activation of the antioxidant response element: degradation of Nrf2 by the 26 S proteasome. J. Biol. Chem. 278:4536-4541.
34. Palmeri, D., and M. H. Malim. 1996. The human T-cell leukemia virus type 1 posttranscriptional trans-activator Rex contains a nuclear export signal. J. Virol. 70:6442-6445.
35. Persaud, D., J. L. Munoz, S. L. Tarsis, E. S. Parks, and W. P. Parks. 1995. Time course and cytokine dependence of human T-cell lymphotropic virus type 1 T-lymphocyte transformation as revealed by a microtiter infectivity assay. J. Virol. 69:6297-6303.
36. Ramadan, E., M. Ward, X. Guo, S. S. Durkin, A. Sawyer, M. Vilela, C. Osgood, A. Pothen, and O. J. Semmes. 2008. Physical and in silico approaches identify DNA-PK in a Tax DNA-damage response interactome. Retrovirology 5:92.
37. Ressler, S., G. F. Morris, and S. J. Marriott. 1997. Human T-cell leukemia virus type 1 Tax transactivates the human proliferating cell nuclear antigen promoter. J. Virol. 71:1181-1190. (Pubitemid 27030290)
38. Rimsky, L., M. Duc Dodon, E. P. Dixon, and W. C. Greene. 1989. Trans-dominant inactivation of HTLV-I and HIV-1 gene expression by mutation of the HTLV-I Rex transactivator. Nature 341:453-456.
39. + T lymphocytes by human T-cell leukemia virus type 1 Tax mutants expressed in a functional molecular clone. J. Virol. 73:4856-4865.
40. Ross, T. M., M. Narayan, Z. Y. Fang, A. C. Minella, and P. L. Green. 2000. Human T-cell leukemia virus type 2 Tax mutants that selectively abrogate NFκB or CREB/ATF activation fail to transform primary human T cells. J. Virol. 74:2655-2662. (Pubitemid 30117575)
41. Ross, T. M., S. M. Pettiford, and P. L. Green. 1996. The tax gene of human T-cell leukemia virus type 2 is essential for transformation of human T lymphocytes. J. Virol. 70:5194-5202.
42. 1- to S-phase transition in human lymphocytes by the human T-cell leukemia/lymphotropic virus type 1 Tax protein. J. Virol. 72:633-640.
43. Silverman, L. R., A. J. Phipps, A. Montgomery, L. Ratner, and M. D. Lairmore. 2004. Human T-cell lymphotropic virus type 1 open reading frame II-encoded p30II is required for in vivo replication: evidence of in vivo reversion. J. Virol. 78:3837-3845.
44. Siomi, H., H. Shida, S. H. Nam, T. Nosaka, M. Maki, and M. Hatanaka. 1988. Sequence requirements for nucleolar localization of human T cell leukemia virus type I pX protein, which regulates viral RNA processing. Cell 55:197-209.
45. Smith, C. L., C. Debouck, M. Rosenberg, and J. S. Culp. 1989. Phosphorylation of serine residue 89 of human adenovirus E1A proteins is responsible for their characteristic electrophoretic mobility shifts, and its mutation affects biological function. J. Virol. 63:1569-1577.
46. Vine, A. M., A. D. Witkover, A. L. Lloyd, K. J. Jeffery, A. Siddiqui, S. E. Marshall, M. Bunce, N. Eiraku, S. Izumo, K. Usuku, M. Osame, and C. R. Bangham. 2002. Polygenic control of human T lymphotropic virus type I (HTLV-I) provirus load and the risk of HTLV-I-associated myelopathy/tropical spastic paraparesis. J. Infect. Dis. 186:932-939.
47. Weichselbraun, I., J. Berger, M. Dobrovnik, H. Bogerd, R. Grassmann, W. C. Greene, J. Hauber, and E. Böhnlein. 1992. Dominant-negative mutants are clustered in a domain of the human T-cell leukemia virus type I Rex protein: implications for trans dominance. J. Virol. 66:4540-4545.
48. Weichselbraun, I., G. K. Farrington, J. R. Rusche, E. Bohnlein, and J. Hauber. 1992. Definition of human immunodeficiency virus type 1 Rev and human T-cell leukemia virus type 1 Rex protein activation domain by functional exchange. J. Virol. 66:2583-2587.
49. Xie, L., and P. L. Green. 2005. Envelope is a major viral determinant of the distinct in vitro cellular transformation tropism of human T-cell leukemia virus type 1 (HTLV-1) and HTLV-2. J. Virol. 79:14536-14545. (Pubitemid 41636252)
50. Xie, L., B. Yamamoto, A. Haoudi, O. J. Semmes, and P. L. Green. 2006. PDZ binding motif of HTLV-1 Tax promotes virus-mediated T-cell proliferation in vitro and persistence in vivo. Blood 107:1980-1988.
51. Yang, X. J. 2005. Multisite protein modification and intramolecular signaling. Oncogene 24:1653-1662.
52. Ye, J., L. Xie, and P. L. Green. 2003. Tax and overlapping Rex sequences do not confer the distinct transformation tropisms of human T-cell leukemia virus types 1 and 2. J. Virol. 77:7728-7735. (Pubitemid 36792769)
53. Yip, M. T., W. S. Dynan, P. L. Green, A. C. Black, S. J. Arrigo, A. Torbati, S. Heaphy, C. Ruland, J. D. Rosenblatt, and I. S. Y. Chen. 1991. Human T-cell leukemia virus (HTLV) type II Rex protein binds specifically to RNA sequences of the HTLV long terminal repeat but poorly to the human immunodeficiency virus type 1 Rev-responsive element. J. Virol. 65:2261-2272.
54. Yoshida, M. 2005. Discovery of HTLV-1, the first human retrovirus, its unique regulatory mechanisms, and insights into pathogenesis. Oncogene 24:5931-5937. (Pubitemid 43086111)
55. Younis, I., and P. L. Green. 2005. The human T-cell leukemia virus Rex protein. Front. Biosci. 10:431-445. (Pubitemid 40552765)